FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Conti

Research Profile

Chemicals & Drugs

Procedures

Living Beings

Concepts & Ideas

Tissue Distribution

Anatomy

Tumor Cell Line

Disorders

Co-author Network

Publications

TOP 3
Kye-Il Joo; Chi-Lin Lee; Zibo Li; Shuanglong Liu; Yarong Liu; Michael K Wong; Liang Xiao; Peter S Conti; Pin Wang
Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs.
Dan Li; Zibo Li; Ren Liu; Shuanglong Liu; Ryan Park; Hong Shan; Parkash S Gill; Lindsey Hughes; Valery Krasnoperov; Peter S Conti
Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring.
Kai Chen; Lindsey D Hughes; Guoquan Li; Wenhui Ma; Ryan Park; Jing Wang; Weidong Yang; Li-Peng Yap; Peter S Conti
Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Conti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kye-Il Joo; Chi-Lin Lee; Zibo Li; Shuanglong Liu; Yarong Liu; Michael K Wong; Liang Xiao; Peter S Conti; Pin Wang
Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs.
Biomaterials 2013;34(12):3098-109.
2013: Dan Li; Zibo Li; Ren Liu; Shuanglong Liu; Ryan Park; Hong Shan; Parkash S Gill; Lindsey Hughes; Valery Krasnoperov; Peter S Conti
Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring.
Molecular pharmaceutics 2013;10(1):329-36.
2013: Kai Chen; Lindsey D Hughes; Guoquan Li; Wenhui Ma; Ryan Park; Jing Wang; Weidong Yang; Li-Peng Yap; Peter S Conti
Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression.
Molecular pharmaceutics 2013;10(1):417-27.
2013: Shuanglong Liu; Hong Shan; François P Gabbaï; Lauren Leamer; Dan Li; Zibo Li; Tzu-Pin Lin; Peter S Conti
Lewis acid-assisted isotopic 18F-19F exchange in BODIPY dyes: facile generation of positron emission tomography/fluorescence dual modality agents for tumor imaging.
Theranostics 2013;3(3):181-9.
2013: Shuanglong Liu; Ryan Park; Peter S Conti; Zibo Li
"Kit like" (18)F labeling method for synthesis of RGD peptide-based PET probes.
American journal of nuclear medicine and molecular imaging 2013;3(1):97-101.
2012: Shuanglong Liu; Ryan Park; Hong Shan; Li-Peng Yap; Chiun-Wei Huang; Dan Li; Zibo Li; Peter S Conti
Efficient construction of PET/fluorescence probe based on sarcophagine cage: an opportunity to integrate diagnosis with treatment.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2012;14(6):718-24.
2012: Chiun-Wei Huang; Zibo Li; Peter S Conti
Radioactive smart probe for potential corrected matrix metalloproteinase imaging.
Bioconjugate chemistry 2012;23(11):2159-67.
2012: Kai Chen; Zibo Li; Peter S Conti
Microwave-assisted one-pot radiosynthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-β-d-arabinofuranosyluracil ([18F]-FMAU).
Nuclear medicine and biology 2012;39(7):1019-25.
2012: Hossein Jadvar; Lingyun Ji; Jacek K Pinski; Peter S Conti; Bhushan Desai; Tanya B Dorff; Susan G Groshen; Mitchell E Gross; David I Quinn
Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer.
Clinical nuclear medicine 2012;37(7):637-43.
2012: Kai Chen; Xiaoyuan Chen; Daiming Fan; Xiaoli Hui; Ryan Park; Kaichun Wu; Li-Peng Yap; Peter S Conti
A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
Amino acids 2012;42(4):1329-37.
2012: Kai Chen; Peter S Conti; Daiming Fan; Xiaoli Hui; Ying Ma; Gang Niu; Xilin Sun; Kaichun Wu; Li-Peng Yap; Xiaoyuan Chen
Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2012;14(1):96-105.
2012: Fernando Safdie; Weijun Wang; Min Wei; Sebastian Brandhorst; Thomas C Chen; Peter S Conti; Saewon Hwang; Changhan Lee; Valter D Longo
Fasting enhances the response of glioma to chemo- and radiotherapy.
PloS one 2012;7(9):e44603.
2012: Shuanglong Liu; Ryan Park; Hong Shan; Li-Peng Yap; Chiun-Wei Huang; Dan Li; Zibo Li; Peter S Conti
The efficient synthesis and biological evaluation of novel bi-functionalized sarcophagine for (64)cu radiopharmaceuticals.
Theranostics 2012;2(6):589-96.
2011: Chiun-Wei Huang; Zibo Li; Peter S Conti
In vivo near-infrared fluorescence imaging of integrin α2β1 in prostate cancer with cell-penetrating-peptide-conjugated DGEA probe.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(12):1979-86.
2011: Zibo Li; Tzu-Pin Lin; Shuanglong Liu; François P Gabbaï; Chiun-Wei Huang; Todd W Hudnall; Peter S Conti
Rapid aqueous [18F]-labeling of a bodipy dye for positron emission tomography/fluorescence dual modality imaging.
Chemical communications (Cambridge, England) 2011;47(33):9324-6.
2011: Shuanglong Liu; Ryan Park; Li-Peng Yap; Chiun-Wei Huang; Zibo Li; Peter S Conti
Efficient preparation and biological evaluation of a novel multivalency bifunctional chelator for 64Cu radiopharmaceuticals.
Chemistry (Weinheim an der Bergstrasse, Germany) 2011;17(37):10222-5.
2011: Chiun-Wei Huang; Zibo Li; Hancheng Cai; Kai Chen; Tony Shahinian; Peter S Conti
Design, synthesis and validation of integrin α2β1-targeted probe for microPET imaging of prostate cancer.
European journal of nuclear medicine and molecular imaging 2011;38(7):1313-22.
2011: Maurice Henry Zissen; Pamela Kunz; Murugesan Subbarayan; Frederick T Chin; Peter S Conti; George A Fisher; Andrew Quon
18F-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases.
Nuclear medicine communications 2011;32(5):343-7.
2011: Chiun-Wei Huang; Zibo Li; Hancheng Cai; Tony Shahinian; Peter S Conti
Biological stability evaluation of the α2β1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptide.
Bioconjugate chemistry 2011;22(2):256-63.
2010: Zibo Li; Hancheng Cai; Matthew Hassink; Melissa L Blackman; Richard C D Brown; Peter S Conti; Joseph M Fox
Tetrazine-trans-cyclooctene ligation for the rapid construction of 18F labeled probes.
Chemical communications (Cambridge, England) 2010;46(42):8043-5.
2010: Hancheng Cai; Zibo Li; Chiun-Wei Huang; Anthony H Shahinian; Hui Wang; Ryan Park; Peter S Conti
Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression.
Bioconjugate chemistry 2010;21(8):1417-24.
2010: Rodrigo S Lacruz; Antonio Nanci; Shane N White; Xin Wen; Hongjun Wang; Sylvia F Zalzal; Vivian Q Luong; Verna L Schuetter; Peter S Conti; Ira Kurtz; Michael L Paine
The sodium bicarbonate cotransporter (NBCe1) is essential for normal development of mouse dentition.
The Journal of biological chemistry 2010;285(32):24432-8.
2010: Hancheng Cai; Zibo Li; Chiun-Wei Huang; Ryan Park; Anthony H Shahinian; Peter S Conti
An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
Nuclear medicine and biology 2010;37(1):57-65.
2009: Zheng Li; Quanzheng Li; Dimitrios Pantazis; Xiaoli Yu; Peter S Conti; Richard M Leahy
Controlling familywise error rate for matched subspace detection in dynamic FDG PET.
IEEE transactions on medical imaging 2009;28(10):1623-31.
2009: Hancheng Cai; John Fissekis; Peter S Conti
Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and (64)Cu radiolabelling.
Dalton transactions (Cambridge, England : 2003) 2009;(27):5395-400.
2009: Zheng Li; Quanzheng Li; Xiaoli Yu; Peter S Conti; Richard M Leahy
Lesion detection in dynamic FDG-PET using matched subspace detection.
IEEE transactions on medical imaging 2009;28(2):230-40.
2008: Hossein Jadvar; Wei Ye; Susan Groshen; Peter S Conti
[F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland.
Annals of nuclear medicine 2008;22(9):787-93.
2008: Xin Wen; Yanming Zou; Wen Luo; Michel Goldberg; Rex Moats; Peter S Conti; Malcolm Snead; Michael L Paine
Biglycan overexpression on tooth enamel formation in transgenic mice.
Anatomical record (Hoboken, N.J. : 2007) 2008;291(10):1246-53.
2008: Peter S Conti; Alexander J B McEwan; Martin G Pomper
Molecular imaging: the future of modern medicine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(6):16N-20N.
2008: Hossein Jadvar; Alparslan Gurbuz; Xiankui Li; Anthony H Shahinian; Peter S Conti
Choline autoradiography of human prostate cancer xenograft: effect of castration.
Molecular imaging 2008;7(3):147-52.
2008: Gary Ulaner; Patrick M Colletti; Peter S Conti
B-cell non-Hodgkin lymphoma: PET/CT evaluation after 90Y-ibritumomab tiuxetan radioimmunotherapy--initial experience.
Radiology 2008;246(3):895-902.
2008: Hossein Jadvar; Vicki Quan; Robert W Henderson; Peter S Conti
[F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma.
International journal of clinical oncology 2008;13(1):42-7.
2008: Peter S Conti; James R Bading; Peter P Mouton; Jonathan M Links; Mian M Alauddin; John D Fissekis; Hayden T Ravert; John Hilton; Dean F Wong; James H Anderson
In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PET.
Nuclear medicine and biology 2008;35(1):131-41.
2008: Andrei Iagaru; Rinat Masamed; Sant P Chawla; Lawrence R Menendez; Alexander N Fedenko; Peter S Conti
F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas.
Clinical nuclear medicine 2008;33(1):8-13.
2007: Chun-Peng Liao; Chen Zhong; Gohar Saribekyan; James R Bading; Ryan Park; Peter S Conti; Rex Moats; Anton Berns; Wei Shi; Zongxiang Zhou; Alexander Nikitin; Pradip Roy-Burman
Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.
Cancer research 2007;67(15):7525-33.
2007: Mian M Alauddin; Anthony H Shahinian; Ryan Park; Michel Tohme; John D Fissekis; Peter S Conti
In vivo evaluation of 2'-deoxy-2'-[(18)F]fluoro-5-iodo-1-beta-D-arabinofuranosyluracil ([18F]FIAU) and 2'-deoxy-2'-[18F]fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil ([18F]FEAU) as markers for suicide gene expression.
European journal of nuclear medicine and molecular imaging 2007;34(6):822-9.
2007: Mian M Alauddin; Anthony H Shahinian; Ryan Park; Michel Tohme; John D Fissekis; Peter S Conti
Biodistribution and PET imaging of [(18)F]-fluoroadenosine derivatives.
Nuclear medicine and biology 2007;34(3):267-72.
2007: Hossein Jadvar; Robert W Henderson; Peter S Conti
[F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
Journal of computer assisted tomography 2007;31(2):223-8.
2007: Andrei Iagaru; Rinat Masamed; Peter A Singer; Peter S Conti
Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2007;9(2):72-7.
2007: Andrei Iagaru; Rinat Masamed; Sravanthi Keesara; Peter S Conti
Breast MRI and 18F FDG PET/CT in the management of breast cancer.
Annals of nuclear medicine 2007;21(1):33-8.
2006: Andrei Iagaru; Sant Chawla; Lawrence Menendez; Peter S Conti
18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas.
Nuclear medicine communications 2006;27(10):795-802.
2006: Nicole M Sodir; Xuan Chen; Ryan Park; Andrea E Nickel; Peter S Conti; Rex Moats; James R Bading; Darryl Shibata; Peter W Laird
Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice.
Cancer research 2006;66(17):8430-8.
2006: Andrei Iagaru; Rinat Masamed; Peter A Singer; Peter S Conti
2-Deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and positron emission tomography/computed tomography diagnosis of patients with recurrent papillary thyroid cancer.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(5):309-14.
2006: Hossein Jadvar; Robert W Henderson; Peter S Conti
2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(3):193-200.
2006: Xiaoyuan Chen; Ryan Park; Vazgen Khankaldyyan; Ignacio Gonzales-Gomez; Michel Tohme; Rex Moats; James R Bading; Walter E Laug; Peter S Conti
Longitudinal microPET imaging of brain tumor growth with F-18-labeled RGD peptide.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(1):9-15.
2005: Abhijit Chaudhari; Felix Darvas; James R Bading; Rex Moats; Peter S Conti; Desmond J Smith; Simon R Cherry; Richard M Leahy
Hyperspectral and multispectral bioluminescence optical tomography for small animal imaging.
Physics in medicine and biology 2005;50(23):5421-41.
2005: Peter S Conti; Christine White; Peter Pieslor; Arturo Molina; Jacqueline Aussie; Paul Foster
The role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(11):1812-8.
2005: Hossein Jadvar; Li Xiankui; Anthony H Shahinian; Ryan Park; Michel Tohme; Jacek Pinski; Peter S Conti
Glucose metabolism of human prostate cancer mouse xenografts.
Molecular imaging 2005;4(2):91-7.
2005: Xiaoyuan Chen; Eric M Sievers; Yingping Hou; Ryan Park; Michel Tohme; Robert D Bart; Ross M Bremner; James R Bading; Peter S Conti
Integrin alpha v beta 3-targeted imaging of lung cancer.
Neoplasia (New York, N.Y.) 2005;7(3):271-9.
2005: Peter S Conti
The future of radioimmunotherapy: a PET perspective.
Seminars in oncology 2005;32(1 Suppl 1):S63-7.
2004: Mian M Alauddin; Anthony H Shahinian; Ryan Park; Michel Tohme; John D Fissekis; Peter S Conti
Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(12):2063-9.
2004: Xiaoyuan Chen; Peter S Conti; Rex Moats
In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts.
Cancer research 2004;64(21):8009-14.
2004: Daniel Cham; Robert Henderson; Peter S Conti
Virchow's node on F-18 FDG PET/CT.
Clinical nuclear medicine 2004;29(11):770-2.
2004: Hossein Jadvar; Peter S Conti
The reproductive tract.
Seminars in nuclear medicine 2004;34(4):262-73.
2004: Hossein Jadvar; Sherief Gamie; Lalitha Ramanna; Peter S Conti
Musculoskeletal system.
Seminars in nuclear medicine 2004;34(4):254-61.
2004: Xiaoyuan Chen; Yingping Hou; Michel Tohme; Ryan Park; Vazgen Khankaldyyan; Ignacio Gonzales-Gomez; James R Bading; Walter E Laug; Peter S Conti
Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(10):1776-83.
2004: Xiaoyuan Chen; Shuang Liu; Yingping Hou; Michel Tohme; Ryan Park; James R Bading; Peter S Conti
MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2004;6(5):350-9.
2004: Xiaoyuan Chen; Ryan Park; Yingping Hou; Michel Tohme; Anthony H Shahinian; James R Bading; Peter S Conti
microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(8):1390-7.
2004: Xiaoyuan Chen; Ryan Park; Yingping Hou; Vazgen Khankaldyyan; Ignacio Gonzales-Gomez; Michel Tohme; James R Bading; Walter E Laug; Peter S Conti
MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide.
European journal of nuclear medicine and molecular imaging 2004;31(8):1081-9.
2004: James R Bading; Anthony H Shahinian; Amy Vail; Pravin Bathija; G W Koszalka; Robert T Koda; Mian M Alauddin; John D Fissekis; Peter S Conti
Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.
Nuclear medicine and biology 2004;31(4):407-18.
2004: Mian M Alauddin; Anthony H Shahinian; Ryan Park; Michel Tohme; John D Fissekis; Peter S Conti
Synthesis of 2'-deoxy-2'-[18F]fluoro-5-bromo-1-beta-D-arabinofuranosyluracil ([18F]-FBAU) and 2'-deoxy-2'-[18F]fluoro-5-chloro-1-beta-D-arabinofuranosyl-uracil ([18F]-FCAU), and their biological evaluation as markers for gene expression.
Nuclear medicine and biology 2004;31(4):399-405.
2004: Xiaoyuan Chen; Michel Tohme; Ryan Park; Yingping Hou; James R Bading; Peter S Conti
Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide.
Molecular imaging 2004;3(2):96-104.
2004: Mian M Alauddin; Anthony H Shahinian; Erlinda M Gordon; Peter S Conti
Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model.
Molecular imaging 2004;3(2):76-84.
2004: Xiaoyuan Chen; Ryan Park; Anthony H Shahinian; Michel Tohme; Vazgen Khankaldyyan; Mohammed H Bozorgzadeh; James R Bading; Rex Moats; Walter E Laug; Peter S Conti
18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.
Nuclear medicine and biology 2004;31(2):179-89.
2004: Peter S Conti
Radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin): the role of the nuclear medicine physician.
Seminars in nuclear medicine 2004;34(1 Suppl 1):2-3.
2004: Xiaoyuan Chen; Ryan Park; Anthony H Shahinian; James R Bading; Peter S Conti
Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation.
Nuclear medicine and biology 2004;31(1):11-9.
2004: Xiaoyuan Chen; Ryan Park; Michel Tohme; Anthony H Shahinian; James R Bading; Peter S Conti
MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide.
Bioconjugate chemistry 2004;15(1):41-9.
2003: Hossein Jadvar; H M Kherbache; Jacek Pinski; Peter S Conti
Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma.
Clinical nephrology 2003;60(6):395-400.
2003: Hossein Jadvar; Jacek Pinski; Peter S Conti
FDG PET in suspected recurrent and metastatic prostate cancer.
Oncology reports 2003;10(5):1485-8.
2003: James R Bading; Paul Yoo; John D Fissekis; Mian M Alauddin; David Z D'Argenio; Peter S Conti
Kinetic modeling of 5-fluorouracil anabolism in colorectal adenocarcinoma: a positron emission tomography study in rats.
Cancer research 2003;63(13):3667-74.
2003: Mian M Alauddin; Angelique Y Louie; Anthony H Shahinian; Thomas J Meade; Peter S Conti
Receptor mediated uptake of a radiolabeled contrast agent sensitive to beta-galactosidase activity.
Nuclear medicine and biology 2003;30(3):261-5.
2003: Hossein Jadvar; Rozet Tatlidil; A A Garcia; Peter S Conti
Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography.
Clinical radiology 2003;58(3):215-21.
2002: Hossein Jadvar; Peter S Conti
Diagnostic utility of FDG PET in multiple myeloma.
Skeletal radiology 2002;31(12):690-4.
2002: Rozet Tatlidil; Hossein Jadvar; James R Bading; Peter S Conti
Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings.
Radiology 2002;224(3):783-7.
2002: Juri Gelovani Tjuvajev; Mikhail Doubrovin; Timothy Akhurst; Shangde Cai; Julius Balatoni; Mian M Alauddin; Ronald Finn; William G Bornmann; Howard T Thaler; Peter S Conti; Ronald Blasberg
Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(8):1072-83.
2002: Mian M Alauddin; Anthony H Shahinian; Erlinda M Gordon; Peter S Conti
Evaluation of 2'-deoxy-2'-flouro-5-methyl-1-beta-D-arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivo.
Molecular imaging 2002;1(2):74-81.
2001: Mian M Alauddin; Anthony H Shahinian; Erlinda M Gordon; James R Bading; Peter S Conti
Preclinical evaluation of the penciclovir analog 9-(4-[(18)F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(11):1682-90.
2001: Rozet Tatlidil; Peter S Conti; P Conti
Gastric and colonic bypass grafts: FDG positron emission tomographic patterns.
Clinical nuclear medicine 2001;26(11):955-6.
2000: James R Bading; Mian M Alauddin; John D Fissekis; Anthony H Shahinian; J Joung; T Spector; Peter S Conti
Blocking catabolism with eniluracil enhances PET studies of 5-[18F]fluorouracil pharmacokinetics.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(10):1714-24.
2000: James R Bading; Anthony H Shahinian; P Bathija; Peter S Conti
Pharmacokinetics of the thymidine analog 2'-fluoro-5-[(14)C]-methyl-1-beta-D-arabinofuranosyluracil ([(14)C]FMAU) in rat prostate tumor cells.
Nuclear medicine and biology 2000;27(4):361-8.
1999: Peter S Conti; J M Durski; F Bacqai; S T Grafton; Peter A Singer
Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography.
Thyroid : official journal of the American Thyroid Association 1999;9(8):797-804.
1999: Mian M Alauddin; Anthony H Shahinian; RK Kundu; Erlinda M Gordon; Peter S Conti
Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors.
Nuclear medicine and biology 1999;26(4):371-6.
1998: B Schmall; Peter S Conti; D J Schaeffer; E L Kleinert
Radiotracer-derived biochemical profiles via a mathematical model: implications for therapeutic intervention.
Nuclear medicine and biology 1998;25(8):799-801.
1998: Mian M Alauddin; Peter S Conti
Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET.
Nuclear medicine and biology 1998;25(3):175-80.
1997: Mian M Alauddin; John D Fissekis; Peter S Conti
Alpha-alkylation of amino acid derivatives: synthesis and chiral resolution of [11C]beta-aminoisobutyric acid.
Nuclear medicine and biology 1997;24(8):771-5.
1996: Laila I Muderspach; F M Muggia; Peter S Conti
Second-look laparotomy for stage III epithelial ovarian cancer: rationale and current issues.
Cancer treatment reviews 1996;21(6):499-511.
1996: Mian M Alauddin; Peter S Conti; S M Mazza; Fayez M Hamzeh; John R Lever
9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): a potential imaging agent of viral infection and gene therapy using PET.
Nuclear medicine and biology 1996;23(6):787-92.
1996: J R Bading; J Kan-Mitchell; Peter S Conti
System A amino acid transport in cultured human tumor cells: implications for tumor imaging with PET.
Nuclear medicine and biology 1996;23(6):779-86.
1996: Peter S Conti; D L Lilien; K Hawley; Jennifer Keppler; Scott T Grafton; J R Bading
PET and [18F]-FDG in oncology: a clinical update.
Nuclear medicine and biology 1996;23(6):717-35.
1996: B Schmall; Peter S Conti; Mian M Alauddin
Synthesis of [11C-methyl]-alpha-aminoisobutyric acid (AIB).
Nuclear medicine and biology 1996;23(3):263-6.
1995: Mian M Alauddin; Hayden T Ravert; John L Musachio; William B Mathews; Robert F Dannals; Peter S Conti
Selective alkylation of pyrimidyl dianions III: no-carrier-added synthesis of [11C-methyl]-thymidine.
Nuclear medicine and biology 1995;22(6):791-4.
1995: Peter S Conti; Mian M Alauddin; J R Fissekis; B Schmall; K A Watanabe
Synthesis of 2'-fluoro-5-[11C]-methyl-1-beta-D-arabinofuranosyluracil ([11C]-FMAU): a potential nucleoside analog for in vivo study of cellular proliferation with PET.
Nuclear medicine and biology 1995;22(6):783-9.
1995: Peter S Conti
Introduction to imaging brain tumor metabolism with positron emission tomography (PET).
Cancer investigation 1995;13(2):244-59.
1994: Peter S Conti; John Hilton; Dean F Wong; Mian M Alauddin; Robert F Dannals; Hayden T Ravert; Alan Wilson; J H Anderson
High performance liquid chromatography of carbon-11 labeled thymidine and its major catabolites for clinical PET studies.
Nuclear medicine and biology 1994;21(8):1045-51.
1994: Peter S Conti; Jennifer Keppler; J M Halls
Positron emission tomography: a financial and operational analysis.
AJR. American journal of roentgenology 1994;162(6):1279-86.
1993: W T Couldwell; Martin H Weiss; Christopher M DeGiorgio; L P Weiner; David R Hinton; G R Ehresmann; Peter S Conti; Michael L J Apuzzo
Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen.
Neurosurgery 1993;32(3):485-9; discussion 489-90.
1992: Peter Brust; ELIAS SHAYA; K J Jeffries; Robert F Dannals; Hayden T Ravert; Alan Wilson; Peter S Conti; Henry N Wagner; Albert Gjedde; A Ermisch
Effects of vasopressin on blood-brain transfer of methionine in dogs.
Journal of neurochemistry 1992;59(4):1421-9.
1992: B Schmall; Peter S Conti; D J Schaeffer; E L Kleinert
Tumor and organ biochemical profiles determined in vivo following uptake of a combination of radiolabeled substrates: potential applications for PET.
American journal of physiologic imaging 1992;7(1):2-11.
1991: Henry N Wagner; Peter S Conti
Advances in medical imaging for cancer diagnosis and treatment.
Cancer 1991;67(4 Suppl):1121-8.
1988: J A Ridge; C Collin; J R Bading; C Hancock; Peter S Conti; J M Daly; J H Raaf
Increased adriamycin levels in hepatic implants of rabbit Vx-2 carcinoma from regional infusion.
Cancer research 1988;48(16):4584-7.
1987: B Schmall; Peter S Conti; R E Bigler; Pat Zanzonico; R E Reiman; R S Benua; Samuel D J Yeh; J R Dahl; R Lee; J S Laughlin
Imaging studies of patients with malignant fibrous histiocytoma using C-11-alpha-aminoisobutyric acid (AIB).
Clinical nuclear medicine 1987;12(1):22-6.
1986: Peter S Conti; P P Sordillo; Emilia Mia Sordillo; B Schmall
Tumor localization of the metabolically trapped radiolabeled substrates 2-deoxy-D-glucose and aminocyclopentanecarboxylic acid in human melanoma heterotransplants.
American journal of clinical oncology 1986;9(6):537-40.
1986: Peter S Conti; P P Sordillo; B Schmall; R S Benua; J R Bading; R E Bigler; J S Laughlin
Tumor imaging with carbon-11 labeled alpha-aminoisobutyric acid (AIB) in a patient with advanced malignant melanoma.
European journal of nuclear medicine 1986;12(7):353-6.
1985: R E Bigler; Pat Zanzonico; B Schmall; Peter S Conti; J R Dahl; L Rothman; George Sgouros; E G MacEwen
Evaluation of [1-11C]-alpha-aminoisobutyric acid for tumor detection and amino acid transport measurement: spontaneous canine tumor studies.
European journal of nuclear medicine 1985;10(1-2):48-55.
1985: Peter S Conti; Emilia Mia Sordillo; P P Sordillo; B Schmall
Tumor localization of alpha-aminoisobutyric acid (AIB) in human melanoma heterotransplants.
European journal of nuclear medicine 1985;10(1-2):45-7.
1984: Harry W Herr; E L Kleinert; Peter S Conti; J H Burchenal; W F Whitmore
Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice.
Cancer research 1984;44(10):4382-5.
1984: B M Sundoro-Wu; B Schmall; Peter S Conti; J R Dahl; P Drumm; J K Jacobsen
Selective alkylation of pyrimidyldianions: synthesis and purification of 11C labeled thymidine for tumor visualization using positron emission tomography.
The International journal of applied radiation and isotopes 1984;35(8):705-8.
1984: Peter S Conti; B Schmall; R E Bigler; Pat Zanzonico; R E Reiman; J R Dahl; J K Jacobsen; R Lee; M B Winstead
Synthesis and purification of sodium [11C]benzoate for physiological and metabolic studies: evaluation in a tumor-bearing dog.
International journal of nuclear medicine and biology 1984;11(2):179-83.
1984: M E Perlman; Peter S Conti; B Schmall; K A Watanabe
Synthesis and purification of the anti-viral agent 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine (FIAC) labeled with iodine-125.
International journal of nuclear medicine and biology 1984;11(3-4):215-8.
1984: B Schmall; Peter S Conti; R E Bigler; Pat Zanzonico; J R Dahl; B M Sundoro-Wu; J K Jacobsen; R Lee
Synthesis and quality assurance of [11C]alpha-aminoisobutyric acid (AIB), a potential radiotracer for imaging and amino acid transport studies in normal and malignant tissues.
International journal of nuclear medicine and biology 1984;11(3-4):209-14.
1981: U Dunzendorfer; B Schmall; R E Bigler; Pat Zanzonico; Peter S Conti; J R Dahl; E Kleinert; W F Whitmore
Synthesis and body distribution of alpha-aminoisobutyric acid-L-11C in normal and prostate cancer-bearing rat after chemotherapy.
European journal of nuclear medicine 1981;6(11):535-8.